Table 2.

Percentage of laboratories in each scheme run, stating the codons (or exons) that were covered in their screening panels for KRAS

Codons or exons tested	KRAS Run 1 (2014–15) n=84	KRAS Run 2 (2014–15) n=84	KRAS Run 1 (2015–16) n=99	KRAS Run 2 (2015–16) n=108
Codons 12/13	82.1	89.3	81.8	76.9
Codon 59	14.3	15.5	20.2	29.6
Codon 61	73.8	85.5	71.7	69.4
Codon 117	16.7	41.6	47.5	50.9
Codon 146	35.7	52.4	54.5	54.6
Exon 2	9.5	9.5	12.1	15.7
Exon 3	9.5	9.5	12.1	15.7
Exon 4	4.8	4.8	10.1	13.9
Not specified	8.3	1.2	6.1	7.4